Universal Technical Institute (UTI) stock surged 12.72% in the pre-market trading session on Thursday, fueled by the company's impressive fiscal Q1 2025 financial performance and strategic initiatives.
The key catalysts driving UTI's pre-market rally include:
- Earnings Beat and Raised Guidance: UTI reported Q1 earnings per share of $0.40, significantly outpacing analysts' estimates of $0.18. Revenue also came in at $201.4 million, up 15.3% year-over-year and exceeding expectations. Encouraged by the strong results, UTI raised its full-year fiscal 2025 revenue guidance to $810 million - $820 million and EPS guidance to $0.96 - $1.04.
- New Partnership with Tesla: UTI announced a major collaboration with Tesla to offer the automaker's START Collision Repair program at its Long Beach campus, beginning in Spring 2025. This 4-month training program will open up employment opportunities for UTI graduates at Tesla's collision repair centers, aligning with the growing demand for skilled technicians in the electric vehicle industry.
- Positive Analyst Sentiment: Several analysts, including Truist and Rosenblatt, have raised their price targets on UTI stock and maintained Buy ratings, reflecting optimism about the company's growth prospects and strategic initiatives.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。